TATA-binding protein-related factor 2 is localized in the cytoplasm of mammalian cells and much of it migrates to the nucleus in response to genotoxic agents.
TBP (TATA-binding protein)-related factor 2 (TRF2) regulates transcription during a nuber of cellular processes. We previously demonstrated that it is localized in the cytoplasm and is translocated to the nucleus by DNA-damaging agents. However, the cytoplasmic localization of TRF2 is controversial. In this study, we reconfirmed its cytoplasmic localization in various ways and examined its nuclear migration. Stresses such as heat shock, redox agents, heavy metals, and osmotic shock did not affect localization whereas genotoxins such as methyl methanesulfonate (MMS), cisplatin, etoposide, and hydroxyurea caused it to migrate to the nucleus. Adriamycin, mitomycin C and gamma-rays had no obvious effect. We determined optimal conditions for the nuclear migration. The proportions of cells with nuclei enriched for TRF2 were 25-60% and 5-10% for stressed cells and control cells, respectively. Nuclear translocation was observed after 1 h, 4 h and 12 h for cisplatin, etoposide and MMS and hydroxyurea, respectively. The association of TRF2 with the chromatin and promoter region of the proliferating cell nuclear antigen (PCNA) gene, a putative target of TRF2, was increased by MMS treatment. Thus TRF2 may be involved in genotoxin-induced transcriptional regulation.
Park
Kyoung-ae
KA
Department of Biology, Faculty of Science, Chiba University, Chiba 263-8522, Japan.
Tanaka
Yuji
Y
Suenaga
Yusuke
Y
Tamura
Taka-aki
TA
D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D000818:Animals; D019556:COS Cells; D002467:Cell Nucleus / Q000378:metabolism*; D002522:Chlorocebus aethiops; D002843:Chromatin / Q000737:chemistry; D002945:Cisplatin / Q000494:pharmacology; D003593:Cytoplasm / Q000737:chemistry*; D004249:DNA Damage; D006367:HeLa Cells; D006657:Histones / Q000032:analysis; D006801:Humans; D008741:Methyl Methanesulfonate / Q000494:pharmacology; D051379:Mice; D009153:Mutagens / Q000494:pharmacology*; D041681:NIH 3T3 Cells; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D035182:TATA Box Binding Protein-Like Proteins / Q000032:analysis* / Q000378:metabolism*; D014158:Transcription, Genetic
D002843:Chromatin; D006657:Histones; D009153:Mutagens; D018809:Proliferating Cell Nuclear Antigen; D035182:TATA Box Binding Protein-Like Proteins; D008741:Methyl Methanesulfonate; D002945:Cisplatin